References
Koeser L and McCrone P. On the use and interpretation of quantile regression in quality-of-life research. Pharmacoeconomics. 2014. doi:10.1007/s40273-013-0105-y
The Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomised controlled study of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007;24:189–200.
Tinelli M, Ryan M, Bond C, Scott A. Valuing benefits to inform a clinical trial in pharmacy: do differences in utility measures at baseline affect the effectiveness of the intervention? Pharmacoeconomics. 2013;31:163–71.
Koenker R, Hallock KF. Quantile regression. J Econ Perspect. 2001;15:143–56.
Seymour J, McNamee P, Scott A, et al. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 2010;19:683–96.
Austin PC, Tu JV, Day PA, et al. The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy. Stat Med. 2005;24:791–816.
Whitehurst DG, Bryan S, Lewis M. Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Med Decis Making. 2011;31:E34–44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tinelli, M., Scott, A., Seymour, J. et al. The Authors’ Reply to Koeser and McCrone: “On the Use and Interpretation of Quantile Regression in Quality-of-Life Research”. PharmacoEconomics 32, 229–230 (2014). https://doi.org/10.1007/s40273-013-0114-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40273-013-0114-x